About Wangsheng

Mr. Wangsheng Li is president of ZeShan Foundation, a privately-funded foundation based in Hong Kong with an international reach. ZeShan is committed to improving the lives of the less privileged through grantmaking, capacity-building, and philanthropy in the areas of health, education, human and social services, and humanitarian aid and post-disaster community rebuilding (www.ZeShanFoundation.org).

Mr. Li has had a lifetime career in the non-profit sector. In recent years, he has focused on equity in and access to quality health care in under-served parts of China and around the world, and on the advancement of philanthropy. One of the key initiatives he’s involved in currently is to create a dedicated international funding program for support of activities toward the elimination of viral hepatitis by 2030 in the context of WHO hepatitis elimination strategy (www.EndHEP2030.org).

This speaker will be presenting at the following session(s)

  • Public private partnership to eliminate hepatitis and the role of the civil society

    Side meeting

    Day: 3 November

    Time: 13:00

    A lunchtime roundtable organized by ZeShan Foundation in partnership with EndHEP2030.

    Achieving the 2030 hepatitis elimination goals will require all stakeholders to work together. The objective of this session is to provide a platform for the participants to discuss their needs and what they can offer. All participants will receive a questionnaire prior to the meeting. We will review the responses according to the following categories: Public health organizations (national and international), donors, philanthropic foundations, industries, civil society, and government entities. We will then use a facilitated discussion (with the audience) to explore the types of partnerships that are needed to achieve the elimination target. This session is recommended for all who want to contribute to helping shape future partnerships. Attendance is by invitation only and all attendees are required to RSVP.

    Presentations:

    Chair: Dr Homie Razavi, Center for Disease Analysis
    Chair: Wangsheng Li, ZeShan Foundation

    • Assessing the need for working capital.
    • Help with hard currency: Overcoming the fact Central Asian, Cuba and some of very low income countries do not have access to hard currency.
    • Mutual recognition of product registration to promote competition and lower prices.
    • How can pooled procurement will work in countries with a tendering process in place?